anmelden
SPI
18.574,54
PKT
-62,04
PKT
-0,33
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.07.15 | Holcim buy | Deutsche Bank AG | |
| 29.07.15 | Holcim kaufen | S&P Capital IQ | |
| 29.07.15 | UBS Underperform | BNP PARIBAS | |
| 29.07.15 | Zurich Insurance Neutral | UBS AG | |
| 29.07.15 | Roche buy | UBS AG | |
| 29.07.15 | Roche overweight | JP Morgan Chase & Co. | |
| 28.07.15 | Holcim Reduce | HSBC | |
| 28.07.15 | UBS overweight | JP Morgan Chase & Co. | |
| 28.07.15 | Holcim Neutral | UBS AG | |
| 28.07.15 | Roche overweight | Barclays Capital | |
| 27.07.15 | UBS Strong Buy | S&P Capital IQ | |
| 27.07.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.07.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 27.07.15 | ABB (Asea Brown Boveri) Neutral | Nomura | |
| 27.07.15 | UBS kaufen | Independent Research GmbH | |
| 27.07.15 | Novartis buy | UBS AG | |
| 27.07.15 | UBS Sell | Société Générale Group S.A. (SG) | |
| 24.07.15 | Roche overweight | Morgan Stanley | |
| 24.07.15 | UBS kaufen | Morgan Stanley | |
| 24.07.15 | UBS overweight | Barclays Capital | |
| 24.07.15 | UBS Underperform | BNP PARIBAS | |
| 24.07.15 | Holcim Neutral | Goldman Sachs Group Inc. | |
| 24.07.15 | UBS buy | Goldman Sachs Group Inc. | |
| 24.07.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 24.07.15 | UBS overweight | JP Morgan Chase & Co. | |
| 24.07.15 | UBS Neutral | UBS AG | |
| 24.07.15 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 24.07.15 | Novartis buy | Kepler Cheuvreux | |
| 23.07.15 | Swiss Re buy | Commerzbank AG | |
| 23.07.15 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 23.07.15 | UBS Halten | Independent Research GmbH | |
| 23.07.15 | Novartis Outperform | BNP PARIBAS | |
| 23.07.15 | Holcim buy | Jefferies & Company Inc. | |
| 23.07.15 | ABB (Asea Brown Boveri) Hold | S&P Capital IQ | |
| 23.07.15 | UBS buy | S&P Capital IQ | |
| 22.07.15 | Novartis Equal weight | Barclays Capital | |
| 22.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 22.07.15 | Novartis Equal-Weight | Morgan Stanley | |
| 22.07.15 | Swiss Re add | Commerzbank AG | |
| 22.07.15 | Holcim Neutral | UBS AG |